SAN DIEGO, Sept. 27, 2012 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, announced today the availability of new migraine patient resources accessible at www.SUMAVELDosePro.com in support of National Pain Awareness Month. One in every four households in the U.S. has a migraine sufferer, which impacts productivity in the workplace, in school and in managing household work. The new resources offer people affected by migraines, as well as caregivers, family and friends, an opportunity to learn more about the condition, view video testimonials from people who suffer from migraines and physicians who specialize in the treatment of headaches, and educate themselves on the U.S. Headache Consortium Migraine Treatment Guidelines provided by the American Headache Society and the American Academy of Neurology.
Migraine attacks can strike at any time and at any speed, and the severity of symptoms can vary from one attack to the next for the same individual. Consequently, the U.S. Headache Consortium Migraine Treatment Guidelines recommend matching the intensity of care with the level of severity and symptoms of the attack. Using a toolbox approach to migraine management allows the migraine sufferer to have the appropriate medication on hand for the specific attack they are experiencing.
Roger K. Cady, MD, associate executive chairman of the National Headache Foundation board of directors, founder of the Headache Care Center in Springfield, MO, and featured testimonial, said, "The goal of migraine treatment is complete relief of pain and symptoms, so you can quickly return to normal functioning. Providing educational resources to help migraine patients talk to their physicians, learn how to manage their condition and use their medication correctly is an important component to migraine treatment."Dr. Cady added, "In my practice, I recommend a toolbox approach to managing migraines. Oral medications are often sufficient for mild or slower onset migraines. However, other treatment options are often needed for patients that wake up with a migraine, experience nausea and vomiting with their migraine, or as a back-up option when migraines come on suddenly or recur."
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts